Okyo Pharma

About:

Okyo Pharma focuses on novel GPCR based therapeutics for eye diseases of high unmet need and non-opioid analgesics for chronic pain.

Website: https://www.okyopharma.com/

Description:

Okyo Pharma focuses on novel GPCR based therapeutics for eye diseases of high unmet need and non-opioid analgesics for chronic pain.

Total Funding Amount:

$12.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2007-01-01

Contact Email:

info(AT)okyopharma.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-10-31

IPO Status:

Public

Industries: